263 related articles for article (PubMed ID: 34032713)
1. Long-term immunosuppression and multiple transplants predispose systemic lupus erythematosus patients with cytopenias to hematologic malignancies.
Lanjewar S; McFarlane IM; Parker KN; Saad H; Haddadin M; Hirsch E; Benyaminov F; Kecelli M; Lazaro D; Bukhari Z; Gupta R; Haseeb MA
Medicine (Baltimore); 2021 May; 100(21):e25985. PubMed ID: 34032713
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow as a target organ of systemic lupus erythematosus: analysis of cases with myelofibrosis.
Üsküdar Cansu D; Üsküdar Teke H; Işiksoy S; Korkmaz C
Int J Rheum Dis; 2018 May; 21(5):1049-1059. PubMed ID: 29671953
[TBL] [Abstract][Full Text] [Related]
3. Indications for bone marrow examination in autoimmune disorders with concurrent haematologic alterations.
Papageorgiou A; Ziakas PD; Tzioufas AG; Voulgarelis M
Clin Exp Rheumatol; 2013; 31(1):76-83. PubMed ID: 23010147
[TBL] [Abstract][Full Text] [Related]
4. Management of immune cytopenias in patients with systemic lupus erythematosus - Old and new.
Newman K; Owlia MB; El-Hemaidi I; Akhtari M
Autoimmun Rev; 2013 May; 12(7):784-91. PubMed ID: 23462431
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow histological findings in systemic lupus erythematosus with hematologic abnormalities: a clinicopathological study.
Voulgarelis M; Giannouli S; Tasidou A; Anagnostou D; Ziakas PD; Tzioufas AG
Am J Hematol; 2006 Aug; 81(8):590-7. PubMed ID: 16823830
[TBL] [Abstract][Full Text] [Related]
6. Hematologic malignancies in patients with cryoglobulinemia: association with autoimmune and chronic viral diseases.
Trejo O; Ramos-Casals M; López-Guillermo A; García-Carrasco M; Yagüe J; Cervera R; Font J; Ingelmo M
Semin Arthritis Rheum; 2003 Aug; 33(1):19-28. PubMed ID: 12920693
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of rituximab for systemic lupus erythematosus-associated immune cytopenias: A multicenter retrospective cohort study of 71 adults.
Serris A; Amoura Z; Canouï-Poitrine F; Terrier B; Hachulla E; Costedoat-Chalumeau N; Papo T; Lambotte O; Saadoun D; Hié M; Blanche P; Lioger B; Gottenberg JE; Godeau B; Michel M
Am J Hematol; 2018 Mar; 93(3):424-429. PubMed ID: 29247540
[TBL] [Abstract][Full Text] [Related]
8. Chronic myelomonocytic leukemia mimicking hematologic systemic lupus erythematosus.
Moura CA; Santiago M; Neto J; Gomes de Souza VH; Moura CG
Lupus; 2017 Feb; 26(2):204-207. PubMed ID: 27365372
[TBL] [Abstract][Full Text] [Related]
9. Clinical Features of Systemic Lupus Erythematosus Patients Complicated With Evans Syndrome: A Case-Control, Single Center Study.
Zhang L; Wu X; Wang L; Li J; Chen H; Zhao Y; Zheng W
Medicine (Baltimore); 2016 Apr; 95(15):e3279. PubMed ID: 27082565
[TBL] [Abstract][Full Text] [Related]
10. [Hematological abnormality and clinical characteristics in systemic lupus erythematosus].
Hu XM; Fan ZR; Zhou SY; Wei W; Zhu BH; Cao YF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Apr; 12(2):170-3. PubMed ID: 15157327
[TBL] [Abstract][Full Text] [Related]
11. Myeloid leukaemia in systemic lupus erythematosus--a nested case-control study based on Swedish registers.
Löfström B; Backlin C; Sundström C; Hellström-Lindberg E; Ekbom A; Lundberg IE
Rheumatology (Oxford); 2009 Oct; 48(10):1222-6. PubMed ID: 19608725
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow involvement in systemic lupus erythematosus.
Chalayer E; Costedoat-Chalumeau N; Beyne-Rauzy O; Ninet J; Durupt S; Tebib J; Asli B; Lambotte O; Ffrench M; Vasselon C; Cathébras P
QJM; 2017 Nov; 110(11):701-711. PubMed ID: 28525589
[TBL] [Abstract][Full Text] [Related]
13. Indications for bone marrow examinations in rheumatology.
Teke HÜ; Cansu DÜ; Korkmaz C
Rheumatol Int; 2019 Jul; 39(7):1221-1228. PubMed ID: 31041504
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow abnormalities in systemic lupus erythematosus with peripheral cytopenia.
Wanitpongpun C; Teawtrakul N; Mahakkanukrauh A; Siritunyaporn S; Sirijerachai C; Chansung K
Clin Exp Rheumatol; 2012; 30(6):825-9. PubMed ID: 23101438
[TBL] [Abstract][Full Text] [Related]
15. [Neoplasia in patients with systemic lupus erythematosus: analysis of two cases of hematological malignancies].
Suszek D; Jeleniewicz R; Majdan M
Ann Acad Med Stetin; 2011; 57(3):28-31; discussion 31-2. PubMed ID: 23383545
[TBL] [Abstract][Full Text] [Related]
16. Clinical assessment and management of cytopenias in lupus patients.
Levine AB; Erkan D
Curr Rheumatol Rep; 2011 Aug; 13(4):291-9. PubMed ID: 21503695
[TBL] [Abstract][Full Text] [Related]
17. Relapses are common in severe hematologic systemic lupus erythematosus and may be prevented by early institution of immunosuppressive agents: Α real-life single-center study.
Moysidou GS; Garantziotis P; Nikolopoulos D; Katsimbri P; Fanouriakis A; Boumpas DT
Lupus; 2023 Feb; 32(2):225-230. PubMed ID: 36490217
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of patients with systemic lupus erythematosus (SLE) and non-Hodgkin's lymphoma (NHL).
King JK; Costenbader KH
Clin Rheumatol; 2007 Sep; 26(9):1491-4. PubMed ID: 17297594
[TBL] [Abstract][Full Text] [Related]
19. The age-risk relationship of haematologic malignancies in female patients with systemic lupus erythematosus: a nationwide retrospective cohort study.
Lin YC; Yen JH; Chang SJ; Lin YC
Lupus; 2012 Oct; 21(11):1250-6. PubMed ID: 22740427
[TBL] [Abstract][Full Text] [Related]
20. [Burkitt's lymphoma in a patient with systemic lupus erythematosus treated with immunosuppressive drugs. A case report].
Bellier C; Khellaf M; Lambotte O; Godeau B
Rev Med Interne; 2006 Mar; 27(3):244-7. PubMed ID: 16406163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
